C57BL/6N-Atm1Brd Bach2tm1a(EUCOMM)Wtsi/WtsiOrl

Status

Available to order

EMMA IDEM:08168
International strain nameC57BL/6N-Atm1Brd Bach2tm1a(EUCOMM)Wtsi/WtsiOrl
Alternative nameEPD0689_1_H02
Strain typeTargeted Mutant Strains
Allele/Transgene symbolBach2tm1a(EUCOMM)Wtsi
Gene/Transgene symbolBach2
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider Wellcome Trust Sanger Institute
Provider affiliationWellcome Trust Sanger Institute
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0689_1_H02. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6N

Disease and phenotype information

IMPC phenotypes (allele matching)
  • decreased bone mineral density / IMPC
  • increased neutrophil cell number / IMPC
  • increased monocyte cell number / IMPC
  • abnormal bone structure / IMPC
  • decreased regulatory T cell number / IMPC
  • increased eosinophil cell number / IMPC
  • decreased B cell number / IMPC
  • increased macrophage cell number / IMPC
  • thrombocytosis / IMPC
  • decreased circulating creatinine level / IMPC
  • increased NK cell number / IMPC
  • decreased follicular B cell number / IMPC
  • decreased mature B cell number / IMPC
  • increased immature B cell number / IMPC
  • increased circulating iron level / IMPC
  • decreased bone mineral content / IMPC
  • increased CD4-positive, alpha-beta memory T cell number / IMPC
  • increased CD8-positive, alpha-beta memory T cell number / IMPC
  • increased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • increased KLRG1-positive NK cell number / IMPC
  • increased Ly6C high monocyte number / IMPC
  • increased Ly6C low monocyte number / IMPC
  • increased KLRG1+ CD8 alpha-beta T cell number / IMPC
  • increased KLRG1+ CD4 alpha-beta T cell number / IMPC
  • increased KLRG1-positive gamma-delta T cell number / IMPC
  • decreased memory-marker NK cell number / IMPC
  • increased memory-marker NK cell number / IMPC
  • increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • decreased CD8-positive, naive alpha-beta T cell number / IMPC
  • increased memory-marker CD4-negative NK T cell number / IMPC
  • increased KLRG1-positive CD4-negative NK T cell number / IMPC
  • decreased CD11b-high dendritic cell number / IMPC
  • increased CD11b-low dendritic cell number / IMPC
  • increased CD103-positive CD11b-low dendritic cell number / IMPC
  • increased effector memory T-helper cell number / IMPC
IMPC phenotypes (gene matching)
  • increased KLRG1-positive NK cell number / IMPC
  • decreased mature B cell number / IMPC
  • abnormal optic disk morphology / IMPC
  • increased monocyte cell number / IMPC
  • increased KLRG1+ CD4 alpha-beta T cell number / IMPC
  • decreased transitional stage B cell number / IMPC
  • increased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
  • decreased circulating creatinine level / IMPC
  • increased pulmonary respiratory rate / IMPC
  • increased KLRG1+ CD8 alpha-beta T cell number / IMPC
  • hyperactivity / IMPC
  • increased effector memory T-helper cell number / IMPC
  • decreased regulatory T cell number / IMPC
  • increased eosinophil cell number / IMPC
  • decreased memory-marker CD4-negative NK T cell number / IMPC
  • decreased food intake / IMPC
  • increased CD4-positive, alpha-beta memory T cell number / IMPC
  • increased KLRG1-positive CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • decreased B cell number / IMPC
  • increased neutrophil cell number / IMPC
  • increased memory-marker CD4-negative NK T cell number / IMPC
  • decreased CD4-negative NK T cell number / IMPC
  • increased NK cell number / IMPC
  • increased memory-marker NK cell number / IMPC
  • increased memory CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
  • immune system phenotype / IMPC
  • decreased Ly6C-positive immature NK cell number / IMPC
  • increased circulating alkaline phosphatase level / IMPC
  • decreased circulating glucose level / IMPC
  • decreased B-1a cell number / IMPC
  • decreased follicular B cell number / IMPC
  • increased CD8-positive, alpha-beta memory T cell number / IMPC
  • decreased exploration in new environment / IMPC
  • short tibia / IMPC
  • increased circulating amylase level / IMPC
  • increased CD11b-low dendritic cell number / IMPC
  • increased KLRG1-positive CD4-negative NK T cell number / IMPC
  • increased grip strength / IMPC
  • decreased CD11b-high dendritic cell number / IMPC
  • increased KLRG1-positive gamma-delta T cell number / IMPC
  • increased NK T cell number / IMPC
  • decreased bone mineral density / IMPC
  • decreased vertical activity / IMPC
  • limb grasping / IMPC
  • decreased prepulse inhibition / IMPC
  • increased CD103-positive CD11b-low dendritic cell number / IMPC
  • increased granulocyte number / IMPC
  • increased Ly6C low monocyte number / IMPC
  • decreased CD8-positive, naive alpha-beta T cell number / IMPC
  • increased circulating iron level / IMPC
  • increased Ly6C high monocyte number / IMPC
  • decreased marginal zone B cell number / IMPC
  • increased macrophage cell number / IMPC
  • decreased respiratory quotient / IMPC
  • decreased memory-marker NK cell number / IMPC
  • increased circulating aspartate transaminase level / IMPC
  • thrombocytosis / IMPC
  • decreased Ly6C-positive mature NK cell number / IMPC
  • increased immature B cell number / IMPC
  • decreased NK T cell number / IMPC
  • increased circulating unsaturated transferrin level / IMPC
  • decreased B-2 B cell number / IMPC
  • decreased bone mineral content / IMPC
  • abnormal bone structure / IMPC
MGI phenotypes (gene matching)
  • spleen hypoplasia / MGI
  • decreased IgG level / MGI
  • decreased IgA level / MGI
  • abnormal B cell differentiation / MGI
  • abnormal B cell physiology / MGI
  • increased IgM level / MGI
  • abnormal somatic hypermutation frequency / MGI
  • abnormal class switch recombination / MGI
  • decreased B cell number / MGI
  • absent germinal center B cells / MGI
  • decreased marginal zone B cell number / MGI
  • decreased mature B cell number / MGI
  • increased immature B cell number / MGI
  • decreased IgG1 level / MGI
  • decreased IgG2a level / MGI
  • decreased IgG2b level / MGI
  • decreased IgG3 level / MGI
  • myeloid hyperplasia / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).